The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. EFPIA believes that interactions between the pharmaceutical industry and healthcare professionals have a profound and positive influence on the quality of patient treatment and the value of future research and therefore, requires transparency to these interactions through the EFPIA Disclosure Code. Country specific Industry Associations, in the UK the Association of the British Pharmaceutical Industry (ABPI) and in Ireland the Irish Pharmaceutical Healthcare Association (IPHA), transposed this Code into local Codes which went into effect on January 1, 2015.
Takeda supports the principles of transparency put forth by EFPIA and is committed to ensuring we meet the highest degree of integrity expected by our patients, healthcare professionals, healthcare organisations and other stakeholders.
UK Disclosure Reports are available on the ABPI Disclosure UK website
Ireland Disclosure Reports are available on the IPHA Transfer of Value website
Takeda Disclosure Reports - Cco.smbx.gb-UKCompliance@takeda.com
Date of Preparation: March 2021